ARDS Historical PE Ratio image   This ARDS PE ratio history page last updated 5/18/2022
ARDS Historical PE Ratio Chart
Data adjusted for ARDS split history

PeriodPriceGAAPAnnualizedPE
Q1 2022
5/16/2022
1.06-0.44-1.76NA
Q4 2021
3/31/2022
1.76-0.92-3.68NA
Q3 2021
11/10/2021
2.76-1.94-7.76NA
Q2 2021
8/12/2021
4.00-0.55-2.20NA
Q1 2021
5/11/2021
6.25-0.77-3.08NA
Q4 2020
3/30/2021
5.75-0.59-2.36NA
Q3 2020
11/20/2020
7.21-0.65-2.60NA
Q2 2020
8/11/2020
7.18-0.47-1.88NA
Q1 2020
5/12/2020
8.55-0.73-2.92NA
Q4 2019
4/8/2020
5.79-0.62-2.48NA
Q3 2019
11/13/2019
5.00-0.87-3.48NA
Q2 2019
8/12/2019
8.39-1.03-4.12NA
Q1 2019
5/14/2019
9.76-0.99-3.96NA
Q4 2018
3/28/2019
10.56-0.67-2.68NA
Q3 2018
11/13/2018
12.23-1.97-7.88NA
ARDS PE History Chart
PeriodPriceGAAPTTMPE
Q1 2022
5/16/2022
1.06-0.44-3.85NA
Q4 2021
3/31/2022
1.76-0.92-4.18NA
Q3 2021
11/10/2021
2.76-1.94-3.85NA
Q2 2021
8/12/2021
4.00-0.55-2.56NA
Q1 2021
5/11/2021
6.25-0.77-2.48NA
Q4 2020
3/30/2021
5.75-0.59-2.44NA
Q3 2020
11/20/2020
7.21-0.65-2.47NA
Q2 2020
8/11/2020
7.18-0.47-2.69NA
Q1 2020
5/12/2020
8.55-0.73-3.25NA
Q4 2019
4/8/2020
5.79-0.62-3.51NA
Q3 2019
11/13/2019
5.00-0.87-3.56NA
Q2 2019
8/12/2019
8.39-1.03-4.66NA
Q1 2019
5/14/2019
9.76-0.99NANA
Q4 2018
3/28/2019
10.56-0.67NANA
Q3 2018
11/13/2018
12.23-1.97NANA
Quotes delayed 20 minutes

Email EnvelopeFree ARDS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Aridis Pharmaceuticals (ARDS) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

ARDX PE Ratio History
ARNA PE Ratio History
ARPO PE Ratio History
ARQT PE Ratio History
ARTL PE Ratio History
ARVN PE Ratio History
ARWR PE Ratio History
ASMB PE Ratio History
ASRT PE Ratio History
ATEC PE Ratio History
How should the ARDS historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Aridis Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this ARDS Historical PE Ratio page.

What is the average historical PE for ARDS based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The ARDS historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for ARDS based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The ARDS historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the ARDS Historical PE Ratio information for Aridis Pharmaceuticals' stock. The average ARDS historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average ARDS historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this ARDS historical PE result, against the recent PE: when this page was posted on 5/17/2022, the most recent closing price for ARDS had been 1.25, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on ARDS or any other given stock, valuation analysis for ARDS can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Aridis Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ARDS. Thanks for visiting, and the next time you need to research ARDS Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Top Ten Hedge Funds Holding DDEZ, Top Ten Hedge Funds Holding APRN, Top Ten Hedge Funds Holding WINN.

 

ARDS Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.